Langue: anglais
Edité par Wiley & Sons, Incorporated, John, 2010
ISBN 10 : 047075379X ISBN 13 : 9780470753798
Vendeur : Better World Books, Mishawaka, IN, Etats-Unis
Edition originale
EUR 32,05
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
EUR 29,49
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Poor. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In poor condition, suitable as a reading copy. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,1050grams, ISBN:9780470753798.
EUR 50,33
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,1050grams, ISBN:9780470753798.
EUR 145,60
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Management of Heart Failure offers an international perspective on current approaches to treating heart failure. This book describes recent advances in therapeutics and pharmacology, as well as ongoing clinical trials. It gives an authoritative review of av.
EUR 181,63
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. Neuware - This volume present a fresh international perspective on current approaches to treating heart failure. An accessible reference for hospital-based specialists, the book provides an update on recent advances in therapeutics and pharmacology, as well as ongoing trials. Four major sections concentrate on a review of screening, assessment and diagnosis; an update on drug treatments; an update on device therapy; and a description of best practice recommendations for managing clinically challenging cases.